1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : SPECIALTY PHARMACEUTICALS
  4. BAUSCH HEALTH COMPANIES INC
Bausch Health Companies Inc
XNYS: BHC
Download real time
5.890.09(1.55%)
26.38% Fall from 52W High
1.4M
XNYS Volume

XNYS 05 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

Bausch Health Companies Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for Bausch Health Companies Inc share price target, revenues, EPS, net income and more

Bausch Health Companies Inc quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
  • POSITIVE

    Quarterly Revenue Bausch Health Companies Inc Jun-2026 Quarterly Revenue is $2,852 Million which is growth of 12.7% YoY.

  • POSITIVE

    Quarterly Net Profit Bausch Health Companies Inc Jun-2026 Quarterly Net Profit is $258 Million which is growth of 74.3% YoY.

Bausch Health Companies Inc, Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphJun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23
Operating Rev.
2,8522,5242,7962,6812,5302,2592,5592,5102,4032,1532,4082,2382,167
Cost Of Rev.
772738798750764701727696719640705623649
Gross Profit
2,0801,7861,9981,9311,7661,5581,8321,8141,6841,5131,7031,6151,518
⌄
1,3051,2651,1691,2951,3091,2661,2241,2851,2581,2191,2001,1211,136
Operating Profit
775521829636457292608529426294503494382
⌄
-385-392-388-397-452-319-328-339-342-346-356-333-312
Profit Before Tax
348-1,35456218140-47209-2148-69-7-32679
Tax
887715937123911171498405652
⌄
258-1,423-112179148-5893-8510-64-39-37826
Diluted NI Avail to Com Stockholders Ann.
258-1,423-112179148-5893-8510-64-39-37826
Basic EPS
0.7-3.8-0.30.50.4-0.20.3-0.20-0.2-0.1-10.1
Diluted EPS After ExtraOrdinary
0.8-1.40.60.50.1-0.10.40.30.1-0.10.1-0.20.1
Number Of Shares End
375372.8371.8371.3370.9369.6368.9368.4367.9366.8366.1365.4364.8
Net Income Continuing Discontinued Operations
258-1,423-112179148-5893-8510-64-39-37826
Normalized Income
285.6-533.8215.3196.423.7-41153.494.438.1-49.653.4-85.820
Interest Income
111091513119789767
Interest
396402397412465330337346350355363339319
Net Interest Income
-385-392-388-397-452-319-328-339-342-346-356-333-312
EBIT
744-95245363060528354632539828635613398
EBITDA
1,025-657743936912588853647716606685314713
Reconciled Cost Of Rev.
716684744697713652679648671594658575603
Reconciled Depr.
281295290306307305307322318320329301315
Profit From Continuing Operations
260-1,431-103181128-8698-92-1-77-47-38227
Normalized EBITDA
1,0628251,128957776608924858749623839801703
*All financials are in USD Million and price data in USD
Add metric to table
Search...

Bausch Health Companies Inc competitor comparison and performance snapshot within industry

Bausch Health Companies Inc annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Annual Revenue Bausch Health Companies Inc Dec-2025 Annual Revenue is $10,266 Million which is growth of 6.7% YoY.

  • POSITIVE

    Annual Net Profit Bausch Health Companies Inc Dec-2025 Annual Net Profit is $157 Million which is growth of 441.3% YoY.

Bausch Health Companies Inc, Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
⌄
8.1%
5%
 10,2669,6258,7578,1248,4348,0278,6018,3808,7249,67410,446.5
Cost Of Rev. Ann.
8.4%
6%
3,0583,0132,7822,5592,3642,3942,2492,3502,3512,5482,6112,584.7
Gross Profit Ann.
8%
4.7%
7,7957,2536,8436,1985,7606,0405,7786,2516,0296,1767,0637,861.8
Operating Exp. Ann.
5.1%
2.6%
5,0345,0684,9894,5984,3704,4724,4644,9635,5315,6385,9385,452.5
Operating Profit Ann.
16.3%
10.7%
2,7612,1851,8541,6001,3901,5681,3141,2884985381,1252,409.3
⌄
-
-
-1,562-1,556-1,355-1,302-1,450-1,419-1,521-1,600-1,674-1,828-1,828-1,559.9
Other Exp. Ann.
-
-
 -262-332-688-69-1,173-727-1,525-2,978-451-1,732-1,004.7
PBT Ann.
-
-
-732367167-390-129-1,024-934-1,837-4,154-1,741-2,435-155.3
Tax Ann.
43.8%
-
36124723922183-87-375-54-10-4,145-27132.5
⌄
-
-
-1,098157-46-592-225-948-560-1,788-4,1482,404-2,409-291.7
Diluted NI Avail to Com Stockholders Ann.
-
-
-1,098157-46-592-225-948-560-1,788-4,1482,404-2,409-291.7
EPS Ann.
-
-
 0.4-0.1-1.6-0.6-2.6-1.6-5.1-11.86.9-6.9-0.9
Diluted EPS Ann.
-
-
 0.4-0.1-1.6-0.6-2.6-1.6-5.1-11.86.8-6.9-0.9
Number Of Shares End
0.8%
0.9%
 371.8368.9366.1362.6360.1355.9352.7351.9350.5349.7348.4
Total Exp. Ann.
6.3%
3.8%
 8,0817,7717,1576,7346,8666,7137,3137,8828,1868,5498,037.2
Net Income Continuing Discontinued Operations Ann.
-
-
-1,098157-46-592-225-948-560-1,788-4,1482,404-2,409-291.7
Normalized Income Ann.
-
-
163.5379.7236.2-179.8-174.8125.3-26.4-303-1,177.22,734.8-714258.5
Interest Income Ann.
50.8%
29.9%
454833261471312111283.3
Interest Ann.
3.1%
0.9%
1,6071,6041,3881,3281,4641,4261,5341,6121,6851,8401,8361,563.2
EBITDA Ann.
5.2%
5.6%
2,0473,1792,8222,2022,7291,9542,4251,8503502,9572,2674,035.4
Reconciled Cost Of Rev. Ann.
8.7%
6.3%
2,8412,8062,5922,3722,1852,2172,0692,1722,1762,3802,4182,375.5
Reconciled Depr. Ann.
-4.7%
-7.9%
1,1721,2081,2671,2641,3941,5521,8252,0752,8192,8582,8662,627.5
Profit From Continuing Operations Ann.
-
-
-1,093120-72-611-212-937-559-1,783-4,1442,404-2,408-287.8
Normalized EBITDA Ann.
7.2%
1.8%
3,9723,4413,1542,8892,7973,1273,1513,3803,3283,4073,9814,784
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
6.7%
2Y CAGR
8.3%
3Y CAGR
8.1%
5Y CAGR
5%
7Y CAGR
2.9%
10Y CAGR
-0.2%
Total Revenue Annual growth is stable compared to historical averages.
Operating Exp. Ann.
1Y CHG
1.6%
2Y CAGR
5%
3Y CAGR
5.1%
5Y CAGR
2.6%
7Y CAGR
-1.2%
10Y CAGR
-0.7%
Operating Expenses Annual Cr growth is stable compared to historical averages.

Bausch Health Companies Inc balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Total Shareholders Fund Bausch Health Companies Inc Dec-2025 Total Shareholders Fund is $-554 Million which is growth of 56.7% YoY.

  • NEGATIVE

    Total Assets Bausch Health Companies Inc Dec-2025 Total Assets is $26,366 Million which is growth of -0.6% YoY.

Bausch Health Companies Inc, Balance Sheet, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
⌄
0.9%
-3.3%
26,36626,52327,35025,68629,20231,19933,86332,49237,49743,52948,964.5
⌄
0.7%
-3.2%
25,98926,84527,43225,42629,23630,59432,72729,67731,55340,27142,934.7
⌄
-
-
-554-1,279-1,022-692-1065351,0632,7335,8493,1525,911
Total Capitalization Ann.
0.7%
-3.9%
20,03817,66320,91619,64222,54824,46025,72426,81031,08432,99736,176.4
Tangible Assets Ann.
-
-
-16,468-17,917-18,661-18,039-19,511-20,954-22,264-22,410-24,955-31,526-35,724.8
Working Capital Ann.
86.2%
35.7%
1,977-9781,2943064094297213754781,468194.6
Invested Capital Ann.
0.3%
-3.7%
20,26320,33721,36620,07422,54824,46026,95827,03831,29333,00437,014.9
Tangible Book Value Ann.
-
-
-16,468-17,917-18,661-18,039-19,511-20,954-22,264-22,410-24,955-31,526-35,724.8
Borrowings Ann.
0.1%
-2.7%
20,85121,61622,38820,76622,65423,92525,89524,30525,44429,85231,103.9
Net Debt Ann.
-1.2%
-3.5%
19,50820,43521,44120,20222,07223,32022,65223,58424,72429,31030,506.6
Share Issued Ann.
0.8%
0.8%
370.5367.8365.2361.9359.4355.4352.6349.9348.7347.8342.9
Number Of Shares End
0.8%
0.9%
371.8368.9366.1362.6360.1355.9352.7351.9350.5349.7348.4
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Assets Ann.
1Y CHG
-0.6%
2Y CAGR
-1.8%
3Y CAGR
0.9%
5Y CAGR
-3.3%
7Y CAGR
-2.9%
10Y CAGR
-6%
Total Assets Annual is falling faster than historical averages.
Total Current Liabilities Ann.
1Y CHG
-38.1%
2Y CAGR
-1.4%
3Y CAGR
2%
5Y CAGR
-3.2%
7Y CAGR
1.2%
10Y CAGR
-2.4%
Total Current Liabilities Annual Cr is falling faster than historical averages.

Bausch Health Companies Inc ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Book Value Per Share Bausch Health Companies Inc Book Value Per Share is $-5 which is growth of -36.2% YoY.

  • NEUTRAL

    ROE Bausch Health Companies Inc ROE is 0% which is growth of 0% YoY.

Bausch Health Companies Inc, Ratios, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
RoA Ann. %
-
-
--0.17%-2.23%-0.82%-3.14%-1.72%-5.39%-11.85%5.93%-5.21%-0.77%
ROE Ann. %
-
-
-----441.96%-70.09%-94.20%-96.67%53.42%-53.16%-5.20%
ROIC %
-
-
-----0.5-4.6-0.12.6-0.5-0.1
OPM Ann. %
7.5%
5.4%
21.28%19.26%18.27%17.11%18.59%16.37%14.98%5.94%6.17%11.63%23.06%
Inventory Turnover Ratio Ann.
-
-
-1.81.92.32.322.32.42.42.32.3
Asset Turnover Ann. %
-
-
-0.40.30.30.30.30.30.20.20.20.3
Working Capital Turnover Ann.
-42%
-22.6%
5.2-9.86.826.620.618.711.922.418.36.653.7
Quick Ratio Ann.
-
-
-0.50.70.60.50.40.80.70.70.90.6
Current Ratio Ann.
-
-
-0.91.31.11.11.11.11.11.11.41
Interest Coverage Ratio Ann.
-
-
-1.10.70.90.30.4-0.1-1.50.1-0.30.9
LT Debt To Equity Ann.
-
-
-----44.723.28.84.39.55.1
*All financials are in USD Million and price data in USD
Add metric to table
Search...

Bausch Health Companies Inc cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Cash From Operating Activity Bausch Health Companies Inc Dec-2025 Cash From Operating Activity is $1,400 Million which is growth of -12.3% YoY.

  • NEGATIVE

    Net Cash Flow Bausch Health Companies Inc Dec-2025 Net Cash Flow is $63 Million which is growth of -77.1% YoY.

Bausch Health Companies Inc, Cash Flow, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
⌄
-
4.7%
1,4001,5971,032-7281,4261,1111,5011,5012,2902,0872,200.4
⌄
-
-
-595-454-2,145-303409-261-419-1962,887-125-15,577.4
⌄
-
-
-742-8681,475-474-1,513-2,2941,443-1,353-4,963-1,96313,681.8
Cash Plus Cash Eqv. End Of Year Ann.
30.9%
-6.1%
1,3251,2019625912,1191,8163,244723797542597.3
Net Increase In Cash Plus Cash Eqv.s Ann.
-
-
63275362-1,505322-1,4442,525-48214-1304.8
Cash Plus Cash Eqv. Begin Of Year Ann.
-17.2%
-18%
1,2019625912,1191,8163,244723797542597322.6
Income Tax Paid Supplemental Data Ann.
-
-
16361---------
Interest Paid Supplemental Data Ann.
-
-
1,8101,674---------
Capex Ann.
-
-
-407-340-272-268-283-309-278-235-336-291-303.3
Issuance Of Capital Stock Ann.
-
-
-675----1,432.8
Issuance Of Debt Ann.
15.6%
25%
10,5546613,2916,8362,1003,4565,9728,9449,4251,22317,825
Repayment Of Debt Ann.
-
-
-11,191-1,460-1,710-7,846-3,440-5,643-4,418-10,104-14,211-2,439-5,185.8
Repurchase Of Capital Stock Ann.
-
-
---------72.4
Free Cash Flow Ann.
-
4.4%
9931,257760-9961,1438021,2231,2661,9541,7961,897.1
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Cash from Operating Act. Ann.
1Y CHG
-12.3%
2Y CAGR
16.5%
5Y CAGR
4.7%
7Y CAGR
-1%
10Y CAGR
-4.4%
Cash from Operating Activity Annual is falling faster than historical averages.
×